Indeed, in advanced tumors, TGF‐β signaling appears to promote aggressive cancer cell traits, such as epithelial‐to‐mesenchymal transition (EMT), reshaping the tumor microenvironment and enhancing angiogenesis and metastasis [13, 14]. The gene discussed is TGFB1; the disease is neoplasm.